Impoyz FDA Approval History
FDA Approved: Yes (First approved November 28, 2017)
Brand name: Impoyz
Generic name: clobetasol propionate
Dosage form: Cream
Company: Dr. Reddy's Laboratories, Inc.
Treatment for: Plaque Psoriasis
Impoyz (clobetasol propionate) is a high potency topical corticosteroid indicated for the treatment of moderate to severe plaque psoriasis.
Development timeline for Impoyz
| Date | Article |
|---|---|
| Dec 1, 2017 | Approval Dr. Reddy’s Announces Approval of Impoyz (clobetasol propionate) Cream for Plaque Psoriasis |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.